Adam, RosalindKanakarajan, SaravanakumarOnyeakazi, UzunmaColumb, MalachyGalley, Helen2020-03-232020-03-232020Adam, R, Kanakarajan, S, Onyeakazi, U, Columb, M & Galley, H 2020, 'Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP) : a study protocol ', BMJ Open, vol. 10, no. 3, e034443. https://doi.org/10.1136/bmjopen-2019-0344432044-6055ORCID: /0000-0003-3082-6578/work/76975960ORCID: /0000-0002-8497-4982/work/90173549https://hdl.handle.net/2164/13906© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.7935072engchronic painmelatoninCircadian Rhythm/drug effectsanalgesiapain managementsleep medicineQUALITYPREVALENCESLEEP DISTURBANCEIMPACTTHERAPYCLINICAL-TRIALSINDEXR MedicineGeneral MedicineRPhase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP) : a study protocolJournal article10.1136/bmjopen-2019-034443http://www.scopus.com/inward/record.url?scp=85081999686&partnerID=8YFLogxK103